Absolute Resting 13N-Ammonia PET Myocardial Blood Flow for Predicting Myocardial Viability and Recovery of Ventricular Function after Coronary Artery Bypass Grafting

J Nucl Cardiol. 2022 Jun;29(3):987-999. doi: 10.1007/s12350-020-02388-7. Epub 2020 Oct 21.

Abstract

Objective: We aimed to evaluate the feasibility of resting myocardial blood flow (rMBF), quantified with dynamic 13 N-Ammonia (NH3) PET, for identifying myocardial viability and predicting improvement of left ventricular ejection fraction (LVEF) after coronary artery bypass grafting (CABG).

Methods: Ninety-three patients with coronary artery disease (CAD) and chronic LVEF < 45%, scheduled for CABG, had dynamic 13NH3 PET and 18F-FDG PET imaging. The perfusion/metabolism polar maps were categorized in four patterns: normal (N), mismatch (M1), match (M2) and reverse mismatch (RM). The value of rMBF for identifying viable myocardium (M1, RM) and post CABG improvement of LVEF≥8% was analyzed by receiver operating characteristic (ROC) curves. Correlations of rMBF in segments to ΔLVEF post CABG were verified.

Results: Mean rMBFs were significantly different (N=0.60±0.14; M1=0.44±0.07, M2=0.34±0.08, RM=0.53±0.09 ml/min/g, P<0.001). The optimal rMBF cutoff to identify viable myocardium was 0.42 ml/min/g (sensitivity=88.3%, specificity=82.0%) and 0.43 ml/min/g for predicting improvement of LVEF ≥8% (74.6%, 80.0%). The extent and rMBF of combined M1/RM demonstrated a moderate to high correlation to improved LVEF (r=0.78, 0.71, P<0.001).

Conclusion: Resting MBF, derived by dynamic 13NH3 PET, may be positioned as a supplement to 18F-FDG PET imaging for assessing the presence of viable myocardium and predicting potential improvement of LVEF after CABG.

Keywords: 13N-Ammonia; 18F-FDG; Coronary artery bypass grafting; Coronary artery disease; Myocardial blood flow; Myocardial viability; Positron emission computed tomography.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonia*
  • Coronary Artery Bypass
  • Fluorodeoxyglucose F18
  • Humans
  • Myocardial Perfusion Imaging*
  • Myocardium
  • Stroke Volume
  • Ventricular Function, Left / physiology

Substances

  • Fluorodeoxyglucose F18
  • Ammonia